Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
158.62B
Market cap158.62B
Price-Earnings ratio
37.08
Price-Earnings ratio37.08
Dividend yield
6.14%
Dividend yield6.14%
Average volume
30.82M
Average volume30.82M
High today
$28.00
High today$28.00
Low today
$27.48
Low today$27.48
Open price
$27.90
Open price$27.90
Volume
44.32M
Volume44.32M
52 Week high
$29.21
52 Week high$29.21
52 Week low
$23.62
52 Week low$23.62

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $27.74. The company's market cap stands at 158.62B, with a P/E ratio of 37.08 and a dividend yield of 6.14%.

During the trading session on 2026-10-08, Pfizer(PFE) shares reached a daily high of $28.00 and a low of $27.48. At a current price of $27.74, the stock is +0.9% higher than the low and still -0.9% under the high.

Trading activity shows a volume of 44.32M, compared to an average daily volume of 30.82M.

The stock's 52-week range extends from a low of $23.62 to a high of $29.21.

The stock's 52-week range extends from a low of $23.62 to a high of $29.21.

PFE News

TipRanks 5h
Pfizer’s VESPER-OSA 1 Trial Targets Sleep Apnea and Obesity With Monthly Shot

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer is advancing a late-stage trial that targets a common sleep breathing problem in p...

TipRanks 7h
Cboe data shows mixed options sentiment in Pfizer with shares down 1.38%

Cboe data shows mixed options sentiment in Pfizer (PFE), with shares down 38c near $27.61. Options volume roughly in line with average with 26k contracts traded...

The Motley Fool 9h
Pfizer Trades Under 10 Times Forward Earnings With a Yield Near 6%. Here's What History Says Happens Next.

Pfizer (PFE +1.82%) is offering a dividend yield of roughly 6% today. That is well above the roughly 1% yield on offer from the S&P 500 index (^GSPC -0.22%) and...

Pfizer Trades Under 10 Times Forward Earnings With a Yield Near 6%. Here's What History Says Happens Next.

Analyst ratings

59%

of 29 ratings
Buy
31%
Hold
58.6%
Sell
10.3%

More PFE News

Zacks 10h
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in t...

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
24/7 Wall St. 11h
Pfizer's Yield Is Three Times Bigger. Johnson & Johnson's Dividend Has Something Pfizer Does Not

Investing Pfizer’s Yield Is Three Times Bigger. Johnson & Johnson’s Dividend Has Something Pfizer Does Not Pfizer's yield towers over Johnson and Johnson's, but...

Pfizer's Yield Is Three Times Bigger. Johnson & Johnson's Dividend Has Something Pfizer Does Not
TipRanks 12h
Pfizer to cut 300 jobs in Italy, confirms closure of penicillins department

In a statement, CISL, a national trade union in Italy, said, “The meeting held yesterday afternoon at the Ministry of Enterprise and Made in Italy on the disput...

Simply Wall St 12h
Pfizer Is Just One Of These 3 AI Healthcare Stocks

When Samsung reports a nearly ninefold jump in profit powered by AI chips, it signals how much money is chasing computing power for smarter medicine, faster dia...

Pfizer Is Just One Of These 3 AI Healthcare Stocks
Simply Wall St 12h
Pfizer Wins TUKYSA Approval And LITFULO Data, Is It Still 3% Undervalued?

Advertisement Why Pfizer stock is back in focus Pfizer (PFE) has moved back into the spotlight after the FDA cleared TUKYSA as a frontline maintenance option...

Pfizer Wins TUKYSA Approval And LITFULO Data, Is It Still 3% Undervalued?
The Motley Fool 24h
Pfizer Stock: Buy, Sell, or Hold?

Pfizer's (PFE +1.82%) shares have been hovering below $30 for more than two years now. After the company reported some of its best-ever financial performances t...

Pfizer Stock: Buy, Sell, or Hold?
The Motley Fool 3d
Why Pfizer Might Be the Most Underrated Dividend Stock to Buy Right Now

Pfizer (PFE -1.35%) has been a reliable healthcare company to invest in for decades, also providing shareholders with some terrific dividend income along the wa...

Why Pfizer Might Be the Most Underrated Dividend Stock to Buy Right Now

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.